Harold Davidson & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
Harold Davidson & Associates's LLY Position: Q2 2026 in Review
Harold Davidson & Associates increased its Eli Lilly (LLY) stake by 2.1% in Q2 2026, buying an estimated $99.1K and bringing the position to 4,767 shares worth $5.72M. The position accounts for 2.48% of the portfolio, ranked #10.
Harold Davidson & Associates first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Harold Davidson & Associates held 4,767 shares of Eli Lilly worth $5.72M as of Q2 2026.
- Harold Davidson & Associates bought 97 Eli Lilly shares in Q2 2026, an estimated $99.1K.
- Eli Lilly made up 2.48% of Harold Davidson & Associates's portfolio in Q2 2026, its #10 holding.
- Harold Davidson & Associates first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
- 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Harold Davidson & Associates's 13F filing for Q2 2026, filed 15 Jul 2026.